Form 4 · Filed Jul 8, 2026, 09:35 PM UTC
DYN/Dyne Therapeutics, Inc.
Rhodes Jason P — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
10 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | S | sell | 5,000 | $24 | $118,050 | 2,962 |
| Jul 7, 2026 | S | sell | 14,844 | $24 | $350,615 | 1,140,150 |
| Jul 7, 2026 | S | sell | 49,193 | $23 | $1,139,802 | 826,719 |
| Jul 7, 2026 | S | sell | 11,665 | $24 | $275,527 | 815,054 |
| Jul 7, 2026 | S | sell | 124,379 | $23 | $2,881,861 | 4,099,069 |
| Jul 7, 2026 | S | sell | 29,587 | $24 | $698,845 | 4,069,482 |
| Jul 7, 2026 | S | sell | 62,543 | $23 | $1,449,121 | 1,154,994 |
| Jul 6, 2026 | S | sell | 127,182 | $23 | $2,898,478 | 1,217,537 |
| Jul 6, 2026 | S | sell | 100,019 | $23 | $2,279,433 | 875,912 |
| Jul 6, 2026 | S | sell | 253,039 | $23 | $5,766,759 | 4,223,448 |
Source: SEC EDGAR raw filing ↗ · Accession 0001577014-26-000014